Medicated serum of TY (1.05, 2.1, and 4.2 g/kg) dose‐dependently and TGT inhibited the proliferation of HFLS‐RA cells, compared with TNF‐α group (p < .01) (Figure 5A). This evidence concerns the gene TNF and rheumatoid arthritis.